Connect with us

Business insider

Morningstar has handpicked 10 cheap gems from the red-hot ETF market, which is on pace for another record year of inflows, including 4 it says are seriously undervalued.

Reuters Research firm Morningstar says exchange-traded funds "look primed for another banner year." ETFs have added $469 billion in i…

Published

on

trading floor

Reuters

  • Research firm Morningstar says exchange-traded funds “look primed for another banner year.”
  • ETFs have added $469 billion in inflows so far in 2021 and will likely overtake last year’s record $500 billion.
  • Morningstar’s 10 cheap ETF picks concentrate on energy and overseas funds.

  • See more stories on Insider’s business page.

Exchange-traded funds (ETFs) are set for a second straight record-breaking year of inflows, having received $469 billion of investment over the past six months, according to fund research firm Morningstar.

A strong June saw ETFs add $74 billion in inflows, with last year’s headline-grabbing success story ARK Invest pulling in $1.1 billion to return to the top 10 providers list.

“Exchange-traded funds look primed for another banner year, as investors continued to pour in new money last month,” Morningstar analysts Ryan Jackson and Ben Johnsons said in a July 1 research note. “The $500 billion that investors dumped into ETFs last year set an annual record, but that’s likely to be short-lived. ETF inflows are on pace to blow past that figure, perhaps as soon as next month.”

An ETF tracks a particular index, sector, or commodity. Like regular stocks, ETFs are bought and sold on stock exchanges.

Demand for these types of funds have surged since the start of the coronavirus pandemic in March 2020, with investors betting on macroeconomic recovery and both value and growth stocks competing to offer the best returns.

Morningstar analysts compiled a list of 10 undervalued ETFs by dividing the fund’s current price by what they calculated to be its fair value. The price/fair value ratio can be used to calculate which cheap ETFs have them most upside for investors.

Four ETFs had a price/fair value ratio of less than or equal to 0.8, implying that they could be undervalued by more than 20%.

Those 4 funds – the Global X MSCI China Financials ETF, the iShares US Oil Equipment & Services ETF, the VanEck Vectors Oil Services ETF, and the Invesco Dynamic Oil & Gas Services ETF – symbolize the two key themes of Morningstar’s research note. Jackson and Johnson argue that energy funds and foreign stock ETFs are most likely to deliver returns for investors.

Energy funds have enjoyed strong returns so far in 2021, with the aforementioned iShares US oil ETF posting a year-to-date return of 62%. However, Morningstar analysts say that investors are still undervaluing the sector. WTI crude oil prices have risen by 55% in 2021, with the S&P 500 recording gains of 16%.

“This fund – and its energy peers – remain considerably undervalued despite a torrential first half of the year,” Jackson and Johnson said. They listed the SPDR S&P Oil & Gas Equipment & Services ETF as another cheap, undervalued energy fund.

Morningstar also highlighted several foreign ETFs, with a particular focus on China. Global X’s China Energy and China Real Estate ETFs joined the Financials ETF on the list of undervalued funds. The China Energy ETF posted the strongest figures in June, delivering a 4.31% return for investors.

“Investors hunting comparably cheap valuations in a more-diversified portfolio likely need to look overseas,” Jackson and Johnson said. “Foreign stock ETFs dominated the ranks of the cheapest broad-based ETFs at June’s end. Most of these funds zero in on international stocks that look cheap relative to their dividends or other fundamental measures of value.”

Alongside the three Global X China ETFs, they listed the Van Eck Vectors Egypt ETF, which is up 0.28% this year, the Invesco RAFI Strategic Emerging Markets ETF, which has gained 13%, and the Davis Select Worldwide ETF, which is up 10.7%, as undervalued funds set to surge in the second half of 2021.

Source: https://markets.businessinsider.com/news/stocks/investing-etfs-strategy-cheap-picks-to-buy-10-funds-tips-morningstar-2021-7

Business insider

Following Is a Test Release

TESTING – TESTING – TESTING                          TESTING – TESTING – TESTING                          TESTING – TES…

Published

on

TESTING – TESTING – TESTING
TESTING – TESTING – TESTING

TESTING – TESTING – TESTING
TESTING – TESTING – TESTING

TESTING – TESTING – TESTING
TESTING – TESTING – TESTING

TESTING – TESTING – TESTING
TESTING – TESTING – TESTING

TESTING – TESTING – TESTING
TESTING – TESTING – TESTING

TESTING – TESTING – TESTING
TESTING – TESTING – TESTING

TESTING – TESTING – TESTING
TESTING – TESTING – TESTING

TESTING – TESTING – TESTING
TESTING – TESTING – TESTING

TESTING – TESTING – TESTING
TESTING – TESTING – TESTING

TESTING – TESTING – TESTING
TESTING – TESTING – TESTING

Cision View original content:https://www.prnewswire.com/news-releases/httpwwwprnewswirecomnews-releaseshttpwwwprnewswirecomnews-releaseshttpwwwprnewswirecomnews-releaseshttpwwwprnewswirecomnews-releaseshttpwwwprnewswirecomnews-releaseshttpwwwprnewswirecomnews-releaseshttpwwwprnewswirecomnews–0.html

SOURCE PR Newswire

Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post.

Source: https://markets.businessinsider.com/news/stocks/following-is-a-test-release-1030999555

Continue Reading

Business insider

Successful 2020 Tang Prize Award Ceremony Highlights Laureates’ Achievements and Influence

TAIPEI, Nov. 20, 2021 /PRNewswire/ — The 2020 Tang Prize Award Ceremony took place virtually at 2p.m. (GMT+8) on November 20. Eight 2020 recipien…

Published

on

TAIPEI, Nov. 20, 2021 /PRNewswire/ — The 2020 Tang Prize Award Ceremony took place virtually at 2p.m. (GMT+8) on November 20. Eight 2020 recipients of the prize from seven countries, including the U.S., the U.K., Japan, Singapore, Bangladesh, Colombia, and Lebanon, attended this heartwarming event remotely, where they were greeted with congratulations and applause from audiences all over the world. The Tang Prize Foundation would like to thank everyone participating online, sharing with us this glorious and joyful occasion, and witnessing together the celebration of the outstanding achievements and the international influence of eight laureates considered by many as pioneers in their respective fields.

Successful 2020 Tang Prize Award Ceremony Highlights Laureates’ Achievements and Influence

In his opening remarks, Dr. Jenn-Chuan Chern, CEO of the Tang Prize Foundation, explained that the COVID pandemic that engulfed the entire world in 2020 had disrupted the plans the Foundation previously worked out. Though Dr. Samuel Yin, founder of the Tang Prize Foundation, had hoped that once the pandemic receded, the 2020 laureates could travel to Taiwan to receive the awards and take part in a series of activities, the fact that the virus continues to wreak havoc worldwide in 2021 has led the Foundation to finally decide to hold a virtual award ceremony and welcome our friends from every corner of the world to join us in recognizing and honoring the laureates’ remarkable achievements and invaluable contributions. Dr. Chern also expressed his gratitude for the president and members of the Selection Committee, as well as experts and scholars who were involved in the selection process, citing their professionalism, meticulousness, unbiased judgement and great vision as reasons the best candidates could be selected as winners.

Sustainable Development laureate Dr. Jane Goodall joined the ceremony via video link from her home in the U.K. In her acceptance speech, Dr. Goodall thanked “the efforts and friendship of so many amazing people along the way,” especially “the staff, the volunteers and the boards of the Jane Goodall Institutes (JGIs) around the world.” With regard to many global problems facing us today, such as climate change, the loss of biodiversity, and the COVID pandemic, Dr. Goodall assured us that every JGI was doing their best to tackle them. She also praised the JGI in Taiwan, for their excellent work and great accomplishment, adding that she would use the prize money to fund JGIs’ many projects, specially the Roots & Shoots, a program designed to empower young people and now being run in 65 countries.

Dr. Charles Dinarello, one of the three winners of the prize in Biopharmaceutical Science, attended the ceremony through video conferencing from his workplace at the University of Colorado. In his acceptance speech, Dr. Dinarello spoke about feeling “very fortunate” to be in the position of seeing the development of research on IL-1 that has helped “lift the burden of disease.” He also acknowledged many scientists whose contributions have made “IL-1 blocking therapeutics” and other “therapeutic innovations” possible. Finally, he encouraged young researchers to stay positive, “have caution for ethical issues,” and dedicate themselves to their work. All the efforts will eventually pay off, because “science,” he asserted, “has no boundaries.”

Making his acceptance speech from the garden in his house in the U.K., Dr. Marc Feldmann, another recipient of the 2020 prize in Biopharmaceutical Science, pointed out that “news of this award came last year, during the pandemic,” to which many people had lost their lives. But it was an “opportune” moment, as the research of three 2020 laureates in Biopharmaceutical Science is about inflammation, which “is what kills patients with severe COVID.” Therefore, he was pleased to see the discoveries they made being used in clinical trials for the treatment of COVID patients. Receiving the prize also made him reflect on his life, and gave thanks to his colleagues and family. Because of their support, he could have “the opportunity to change the world for the better, for millions of patients.”

Dr. Tadamitsu Kishimoto, also an awardee of the prize in Biopharmaceutical Science, received his prizes remotely in Japan. Speaking from Osaka University’s Immunology Frontier Research Center, he noted the significance of the recognition from the Tang Prize for his lifelong research on IL-6, which resulted in the development of the drug, tocilizumab, now being used in more than 100 countries to ease the pain of millions of patients suffering from rheumatoid arthritis.

Winner of the prize for Sinology Prof. Wang Gungwu gave his acceptance speech through a video call from the National University of Singapore. Pointing out that Sinology as a field deserves further exploration and hoping that “the award of the Tang Prize” would “draw more attention to the value of Sinic civilization to the betterment of the human condition,” he also commended Dr. Samuel Yin “for his wisdom and generosity in establishing the Tang Prize,” particularly for his insight that led to the prize in Sinology.

Representatives from three NGOs that were awarded the prize for Rule of Law, Ms. Syeda Rizwana Hasan of the Bangladesh Environmental Lawyers Association, Prof. Vivian Newman Pont of Dejusticia: The Center for Law, Justice and Society, and Ms. Ghida Frangieh of The Legal Agenda, went online at their homes or offices to receive the awards. Appreciating how the recognition from the Tang Prize has given non-governmental organizations a much-needed boost, they promised to continue the fight for social and environmental justice, for the rights of marginalized groups, and for important issues such as judicial independence, in order to uphold the principles of the rule of law. Winning the Tang Prize has given them renewed impetus to keep soldiering on, and regardless of how difficult the challenges and circumstances are, they know they would persist in their pursuit of progress and innovation.

With the enthusiastic participation of audiences around the globe, the first virtual Tang Prize Award Ceremony has come to a successful end. We hope life will return to normal in the coming year, so that an in-person award ceremony can be held in Taiwan, a tradition of the Tang Prize that has been observed since 2014.

To relive the inspiring moments of this ceremony and witness again the charm of the eight 2020 laureates, please visit our YouTube channel: https://youtu.be/lN0ADXBNT-Q for Chinese subtitles, or https://youtu.be/56GwDm3EL0g for English subtitles.

Media Contact

Media contact: Sophia Lin
Email: thetangmedia@tang-prize.org
Phone number: +886-2-8772-5188#103

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/successful-2020-tang-prize-award-ceremony-highlights-laureates-achievements-and-influence-301419171.html

SOURCE The Tang Prize Foundation

Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post.

Making his acceptance speech from the garden in his house in the U.K., Dr. Marc Feldmann, another recipient of the 2020 prize in Biopharmaceutical Science, pointed out that “news of this award came last year, during the pandemic,” to which many people had lost their lives. But it was an “opportune” moment, as the research of three 2020 laureates in Biopharmaceutical Science is about inflammation, which “is what kills patients with severe COVID.” Therefore, he was pleased to see the discoveries they made being used in clinical trials for the treatment of COVID patients. Receiving the prize also made him reflect on his life, and gave thanks to his colleagues and family. Because of their support, he could have “the opportunity to change the world for the better, for millions of patients.”

Source: https://markets.businessinsider.com/news/stocks/successful-2020-tang-prize-award-ceremony-highlights-laureates-achievements-and-influence-1030992706

Continue Reading

Business insider

Swiss Market Ends Slightly Weak

(RTTNews) – Despite spending much of the day’s session in positive territory, the Switzerland stock market ended slightly weak on Friday. The moo…

Published

on

(RTTNews) – Despite spending much of the day’s session in positive territory, the Switzerland stock market ended slightly weak on Friday.

The mood was cautious amid concerns about rising coronavirus cases and fresh lockdown measures in several countries in Europe.

The benchmark SMI, which rose to 12,622.91 around mid morning, ended the session with a marginal loss of 8.18 points or 0.07% at 12,545.01.

Logitech climbed 4.3%. Lonza Group gained 2.1%, while Givaudan, Partners Group and Geberit advanced 1.3 to 1.5%. Sika, ABB, Novartis, Roche Holding and SGS posted modest gains.

Richemont, UBS Group and Credit Suisse ended lower by 2.4 to 2.5%. Swiss Life Holding, Zurich Insurance Group, Holcim and Swisscom drifted down 1.2 to 1.6%.

In the Swiss Mid Price Index, Flughafen Zurich declined 3.8%, Dufry ended lower by 3.6% and AMS drifted down 2.6%. Julius Baer and Adecco shed 2.2% and 2.1%, respectively.

Zur Rose and VAT Group rallied 3.2% and 3.2%, respectively. Tecan Group gained 2.2% and Lindt & Spruengli moved up 1.7%.

In coronavirus news, Switzerland reported over 6,000 new infections on November 18. Swiss Health Minister Alain Berset said no additional measures were necessary to combat the rise.

Source: https://markets.businessinsider.com/news/stocks/swiss-market-ends-slightly-weak-1030992350

Continue Reading

Trending